IL51797A - Antihistaminic or antianaphylactic pharmaceutical compositions containing n-(4-substituted piperid-1-yl and piperaz-1-yl)alkyl-aza-cyclic derivatives,some novel such compounds and their preparation - Google Patents

Antihistaminic or antianaphylactic pharmaceutical compositions containing n-(4-substituted piperid-1-yl and piperaz-1-yl)alkyl-aza-cyclic derivatives,some novel such compounds and their preparation

Info

Publication number
IL51797A
IL51797A IL51797A IL5179777A IL51797A IL 51797 A IL51797 A IL 51797A IL 51797 A IL51797 A IL 51797A IL 5179777 A IL5179777 A IL 5179777A IL 51797 A IL51797 A IL 51797A
Authority
IL
Israel
Prior art keywords
piperaz
antianaphylactic
piperid
antihistaminic
aza
Prior art date
Application number
IL51797A
Other versions
IL51797A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL51797A0 publication Critical patent/IL51797A0/en
Publication of IL51797A publication Critical patent/IL51797A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL51797A 1976-04-02 1977-03-31 Antihistaminic or antianaphylactic pharmaceutical compositions containing n-(4-substituted piperid-1-yl and piperaz-1-yl)alkyl-aza-cyclic derivatives,some novel such compounds and their preparation IL51797A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67291976A 1976-04-02 1976-04-02
US75306276A 1976-12-21 1976-12-21

Publications (2)

Publication Number Publication Date
IL51797A0 IL51797A0 (en) 1977-05-31
IL51797A true IL51797A (en) 1981-09-13

Family

ID=27100846

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51797A IL51797A (en) 1976-04-02 1977-03-31 Antihistaminic or antianaphylactic pharmaceutical compositions containing n-(4-substituted piperid-1-yl and piperaz-1-yl)alkyl-aza-cyclic derivatives,some novel such compounds and their preparation

Country Status (31)

Country Link
JP (1) JPS52122380A (en)
AT (1) AT357541B (en)
AU (1) AU515173B2 (en)
BG (1) BG36044A3 (en)
CA (1) CA1097646A (en)
CH (1) CH634317A5 (en)
CS (1) CS191337B2 (en)
CY (1) CY1210A (en)
DE (1) DE2714437A1 (en)
DK (1) DK153477C (en)
EG (1) EG12722A (en)
ES (1) ES456690A1 (en)
FI (1) FI66178C (en)
FR (1) FR2346350A1 (en)
GB (1) GB1579365A (en)
GR (1) GR62465B (en)
HU (1) HU179491B (en)
IE (1) IE44942B1 (en)
IL (1) IL51797A (en)
IT (1) IT1086841B (en)
KE (1) KE3338A (en)
LU (1) LU77052A1 (en)
MY (1) MY8400208A (en)
NL (1) NL190522C (en)
NO (1) NO146774C (en)
NZ (1) NZ183506A (en)
PH (1) PH12951A (en)
PT (1) PT66384B (en)
SE (1) SE431333B (en)
SU (1) SU683621A3 (en)
YU (1) YU39992B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181802A (en) * 1978-05-11 1980-01-01 Janssen Pharmaceutica N.V. 1-(Heterocyclylalkyl)-1,3-dihydro-2-H-benzimidazole-2-ones
US4254127A (en) * 1980-04-03 1981-03-03 Janssen Pharmaceutica, N.V. 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives
JPS57106663A (en) * 1980-12-23 1982-07-02 Kyorin Pharmaceut Co Ltd 1,4-disubstituted piperazine derivative and its preparation
ES514340A0 (en) * 1982-06-17 1983-09-01 Ferrer Int "PROCEDURE FOR OBTAINING NEW DERIVATIVES OF PIPERAZINE".
DE3442757A1 (en) * 1984-11-23 1986-05-28 Wella Ag, 6100 Darmstadt USE OF 2-NITROANILINE DERIVATIVES IN HAIR COLORING AGENTS AND NEW 2-NITROANILINE DERIVATIVES
JPS625956A (en) * 1985-07-02 1987-01-12 Terumo Corp Vinyl derivative and 5-lipoxygenase action inhibitor containing same
FR2635524B1 (en) * 1988-08-19 1992-04-24 Adir NOVEL BENZOPYRROLIDINONE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US5169855A (en) * 1990-03-28 1992-12-08 Du Pont Merck Pharmaceutical Company Piperidine ether derivatives as psychotropic drugs or plant fungicides
IT1251144B (en) * 1991-07-30 1995-05-04 Boehringer Ingelheim Italia BENZIMIDAZOLONE DERIVATIVES
AU665816B2 (en) * 1992-03-23 1996-01-18 Janssen Pharmaceutica N.V. Agent for use as an anti-irritant
DE59308382D1 (en) * 1992-11-29 1998-05-14 Clariant Gmbh New asymmetric, halogenated benzophenones and processes for their production
US5883094A (en) * 1995-04-24 1999-03-16 Pfizer Inc. Benzimidazolone derivatives with central dopaminergic activity
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
IT1292409B1 (en) * 1997-06-24 1999-02-08 Bidachem Spa PROCEDURE FOR THE PREPARATION OF OXATOMIDE
GB0009479D0 (en) * 2000-04-17 2000-06-07 Cipla Limited Antihistaminic compounds
AU2002223528A1 (en) * 2000-09-19 2002-04-02 Boeringer Ingelheim Pharma Gmbh & Co. Kg New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
EP1364945A4 (en) 2001-01-30 2005-08-31 Sumitomo Pharma Benzimidazolidinone derivatives
WO2004096794A1 (en) * 2003-05-01 2004-11-11 Vernalis Research Limited Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
US20100029681A1 (en) * 2006-05-26 2010-02-04 Hassan Pajouhesh Heterocyclic compounds as calcium channel blockers
WO2010128516A2 (en) * 2009-05-04 2010-11-11 Symed Labs Limited Process for the preparation of flibanserin involving novel intermediates
CN104926734B (en) * 2015-07-07 2017-04-05 苏州立新制药有限公司 The preparation method of flibanserin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2882271A (en) * 1959-04-14 Xcixcxh
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
US3369022A (en) * 1966-11-07 1968-02-13 Robins Co Inc A H 3-piperazinoalkyl-2-benzoxazolinones
JPS5070389A (en) * 1973-10-30 1975-06-11

Also Published As

Publication number Publication date
GR62465B (en) 1979-04-13
HU179491B (en) 1982-10-28
LU77052A1 (en) 1977-07-22
DE2714437C2 (en) 1989-05-11
NL7703564A (en) 1977-10-04
FI66178B (en) 1984-05-31
IE44942L (en) 1977-10-02
IL51797A0 (en) 1977-05-31
DE2714437A1 (en) 1977-10-20
DK153477B (en) 1988-07-18
NL190522B (en) 1993-11-01
AU2382477A (en) 1978-10-05
NO146774C (en) 1982-12-08
EG12722A (en) 1981-06-30
AU515173B2 (en) 1981-03-19
YU56677A (en) 1983-01-21
CA1097646A (en) 1981-03-17
CH634317A5 (en) 1983-01-31
PH12951A (en) 1979-10-18
YU39992B (en) 1985-06-30
PT66384A (en) 1977-05-01
FI66178C (en) 1984-09-10
FR2346350A1 (en) 1977-10-28
AT357541B (en) 1980-07-10
DK145977A (en) 1977-10-03
BG36044A3 (en) 1984-08-15
JPS52122380A (en) 1977-10-14
SE7703842L (en) 1977-10-03
IT1086841B (en) 1985-05-31
DK153477C (en) 1988-11-21
IE44942B1 (en) 1982-05-19
FI771020A (en) 1977-10-03
CY1210A (en) 1984-04-06
NO146774B (en) 1982-08-30
SU683621A3 (en) 1979-08-30
KE3338A (en) 1983-11-25
GB1579365A (en) 1980-11-19
NL190522C (en) 1994-04-05
NO771168L (en) 1977-10-04
NZ183506A (en) 1980-04-28
SE431333B (en) 1984-01-30
MY8400208A (en) 1984-12-31
FR2346350B1 (en) 1980-10-17
ES456690A1 (en) 1978-07-16
JPS6231707B2 (en) 1987-07-09
ATA230477A (en) 1979-12-15
CS191337B2 (en) 1979-06-29
PT66384B (en) 1979-01-31

Similar Documents

Publication Publication Date Title
IL51797A (en) Antihistaminic or antianaphylactic pharmaceutical compositions containing n-(4-substituted piperid-1-yl and piperaz-1-yl)alkyl-aza-cyclic derivatives,some novel such compounds and their preparation
IL49204A0 (en) N-(4-piperidinyl)-n-phenylamides and-carbamates,their preparation and pharmaceutical compositions containing them
IL53411A0 (en) Novel piperidine and morpholine derivatives their manufacture and pharmaceutical and fungicidal compositions containing them
NZ192653A (en) 4-substituted piperidino-alkanol derivatives and pharmaceutical compositions containing them
IL53639A (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL58579A (en) Nitrogen heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL53043A (en) N-heterocyclylalkyl-(1-aryloxy-2-hydroxy-3-amino-propane)derivatives,their preparation and pharmaceutical compositions containing them
IT1113092B (en) HETEROCYCLIC COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS
IL48963A (en) 4-(benzoylureido)-4-nitro-diphenyl ether derivatives, their preparation and insecticidal compositions containing them
IL50690A0 (en) Novel benzisothiazole derivatives,their preparation and pharmaceutical compositions containing them
IL50869A (en) Heterocyclylthio-ethylimidazole derivatives,their preparation and pharmaceutical compositions containing them
IL49194A0 (en) Novel thiocarbamide derivatives,their preparation and pharmaceutical compositions containing them
IL51339A (en) 3-(substituted)methylene-4-oxa-1-azabicyclo(3.2.0)heptan-7-one derivatives their preparation and pharmaceutical compositions containing them
IL49422A (en) Substitutet 1-(w-triarylalkyl)-4-phenyl-4-piperidine-methanol derivatives, their preparation and pharmaceutical compositions containing them
IL49280A (en) Pharmaceutical compositions containing substituted o-hydroxy-benzophenone derivatives
IL53078A (en) Pharmaceutical compositions containing 2-phenylthio (sulfinyl)-4-alkylphenol derivatives,certain novel such compounds and their preparation
IL50127A0 (en) Pharmaceutical compositions containing 2,1,3-benzothiadiazole derivatives
IL49931A (en) Pharmaceutical compositions comprising 1-phenyl-2,3,4,5-tetrahydro-1h-benzazepine derivatives and certain new such compounds
IL54591A0 (en) Novel benzimidazole derivatives, their manufacture and pharmaceutical compositions containing them
IL52717A (en) Derivatives of2-phenylamino-imidazoline-(2),their preparation and pharmaceutical compositions containing them
IL50542A (en) Substituted pyridinecarboxamides,their manufacture and pharmaceutical compositions containing them
IL50263A (en) 4-(2-benzoyloxy or phenoxyalkanoyl-oxy-3-tert-butylaminopropoxy)indole derivatives,their production and pharmaceutical compositions containing them
IL47503A0 (en) Novel heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL60813A0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
NZ182716A (en) 4-(7-bromo-5-methoxy-2-benzofuranyl)-1,2,3,6-tetrahtdropyridine or-piperidine derivatives and pharmaceutical compositions